These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 21264898)
1. Case-control study of risk factors of myelodysplastic syndromes according to World Health Organization classification in a Chinese population. Lv L; Lin G; Gao X; Wu C; Dai J; Yang Y; Zou H; Sun H; Gu M; Chen X; Fu H; Bao L Am J Hematol; 2011 Feb; 86(2):163-9. PubMed ID: 21264898 [TBL] [Abstract][Full Text] [Related]
2. Integrating WHO 2001-2008 criteria for the diagnosis of Myelodysplastic Syndrome (MDS): a case-case analysis of benzene exposure. Irons RD; Gross SA; Le A; Wang XQ; Chen Y; Ryder J; Schnatter AR Chem Biol Interact; 2010 Mar; 184(1-2):30-8. PubMed ID: 19941839 [TBL] [Abstract][Full Text] [Related]
3. A hospital-based case-control study of acute myeloid leukemia in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification. Wong O; Harris F; Armstrong TW; Hua F Chem Biol Interact; 2010 Mar; 184(1-2):112-28. PubMed ID: 19900423 [TBL] [Abstract][Full Text] [Related]
4. A hospital-based case-control study of acute myeloid leukemia in Shanghai: analysis of personal characteristics, lifestyle and environmental risk factors by subtypes of the WHO classification. Wong O; Harris F; Yiying W; Hua F Regul Toxicol Pharmacol; 2009 Dec; 55(3):340-52. PubMed ID: 19703505 [TBL] [Abstract][Full Text] [Related]
5. A hospital-based case-control study of non-Hodgkin lymphoid neoplasms in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification. Wong O; Harris F; Armstrong TW; Hua F Chem Biol Interact; 2010 Mar; 184(1-2):129-46. PubMed ID: 19900422 [TBL] [Abstract][Full Text] [Related]
6. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Germing U; Strupp C; Kuendgen A; Isa S; Knipp S; Hildebrandt B; Giagounidis A; Aul C; Gattermann N; Haas R Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595 [TBL] [Abstract][Full Text] [Related]
8. [The application of a new prognostic score system for 435 cases of primary myelodysplastic syndrome diagnosed with WHO classification]. Wang XQ; Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):633-7. PubMed ID: 19954053 [TBL] [Abstract][Full Text] [Related]
9. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935 [TBL] [Abstract][Full Text] [Related]
10. [A case-control study of risk factors for myelodysplastic syndromes]. Lv L; Lin GW; Wang XQ; Bao LM; Zou HJ Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Dec; 25(12):705-9. PubMed ID: 18230297 [TBL] [Abstract][Full Text] [Related]
11. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients. Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of regulatory T cells in patients with myelodysplastic syndrome. Hamdi W; Ogawara H; Handa H; Tsukamoto N; Nojima Y; Murakami H Eur J Haematol; 2009 Mar; 82(3):201-7. PubMed ID: 19018862 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow blasts level predicts prognosis in patients with refractory cytopenia with multilineage dysplasia. Wang H; Wang XQ; Xu XP; Lin GW Eur J Haematol; 2009 Dec; 83(6):550-8. PubMed ID: 19737310 [TBL] [Abstract][Full Text] [Related]
15. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts]. Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of MDS subtypes in Shanghai, China: a comparison of the World Health Organization and French American British classifications. Irons RD; Wang X; Gross SA; Bao L; Ryder J; Chen Y; Chen H; Sun H; Zhou J; Ji M; Du X; Fu H; Lin G Leuk Res; 2006 Jul; 30(7):769-75. PubMed ID: 16337268 [TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of WHO classification and MDS 2000 classification in myelodysplastic syndromes]. Akiba M; Matsuda A; Misumi M; Yagasaki F; Bessho M Rinsho Ketsueki; 2001 Dec; 42(12):1162-9. PubMed ID: 11828718 [TBL] [Abstract][Full Text] [Related]
18. A case-control study of myelodysplastic syndromes in Belgrade (Serbia Montenegro). Pekmezovic T; Suvajdzic Vukovic N; Kisic D; Grgurevic A; Bogdanovic A; Gotic M; Bakrac M; Brkic N Ann Hematol; 2006 Aug; 85(8):514-9. PubMed ID: 16691397 [TBL] [Abstract][Full Text] [Related]
19. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis. Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299 [TBL] [Abstract][Full Text] [Related]
20. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome. Knipp S; Strupp C; Gattermann N; Hildebrandt B; Schapira M; Giagounidis A; Aul C; Haas R; Germing U Leuk Res; 2008 Jan; 32(1):33-7. PubMed ID: 17412418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]